Heinz Kalk
About
In The Last Decade
Heinz Kalk
37 papers receiving 117 citations
Peers
Comparison fields: 5 of 53
- Epidemiology 57
- Hepatology 30
- Pediatrics, Perinatology and Child Health 24
- Molecular Biology 21
- Clinical Biochemistry 21
Countries citing papers authored by Heinz Kalk
This map shows the geographic impact of Heinz Kalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Kalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Kalk more than expected).
Fields of papers citing papers by Heinz Kalk
This network shows the impact of papers produced by Heinz Kalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Kalk. The network helps show where Heinz Kalk may publish in the future.
Co-authorship network of co-authors of Heinz Kalk
This figure shows the co-authorship network connecting the top 25 collaborators of Heinz Kalk. A scholar is included among the top collaborators of Heinz Kalk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz Kalk. Heinz Kalk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | [On the clinical aspects of liver diseases]. | 2 |
| 3 | [Diseases after stomach operations]. | 1 |
| 4 | 1 | |
| 5 | Zur Beteiligung der Leber bei der infektiösen Mononucleose: Ferment-Aktivitäts-Bestimmungen in der menschlichen Leber. VIII | 1 |
| 6 | [Notes on corticosteroid therapy of liver diseases]. | 1 |
| 7 | 10 | |
| 8 | Problematik und Klinik der Zellulartherapie | 2 |
| 9 | 5 | |
| 10 | [Posthepatic hyperbilirubinemia (so-called acquired hemolytic icterus following hepatitis)]. | 6 |
| 11 | [Posthepatic hyperbilirubinemia, a frequent sequel to hepatitis]. | 3 |
| 12 | [Posthepatitic hyperbilirubinemia]. | 5 |
| 13 | [Portal hypertension with reference to its surgical treatment]. | 1 |
| 14 | 1 | |
| 15 | [Portal hypertension, with respect to the surgical therapy]. | 1 |
| 16 | [Unusual case of esophageal foreign body]. | 1 |
| 17 | 4 | |
| 18 | [Treatment of chronic hepatitis and biliary cirrhosis with liver extracts]. | 1 |
| 19 | [Aggravation of stomach diseases, in military service especially of gastroduodenal ulcers]. | 1 |
| 20 | [Gastrointestinal disease, especially gastroduodenal ulcer, as a service-connected disability. II]. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.